Ad Prevent Original Ointment
NDC Package 65197-401-99
Package Information
Ad Prevent Original ointment is for skin protectant use: apply as neededfor diaper rash use:change wet and soiled diapers promptlycleanse the diaper area, and allow to dryapply ointment liberally as often as necessary, with each diaper change, especially at bedtime or anytime when exposure to wet diapers may be prolonged . This formulation utilizes a ointment delivery system. Marketed by Wellspring Pharmaceutical Corporation, this product is identified by NDC 65197-401 and is authorized under FDA application M016.
Identification & Billing
- RxCUI: 664981 - lanolin 15.5 % / petrolatum 53.4 % Topical Ointment
- RxCUI: 664981 - lanolin 0.155 MG/MG / petrolatum 0.534 MG/MG Topical Ointment
- RxCUI: 664981 - lanolin 15.5 GM per 100 GM / petrolatum 53.4 GM per 100 GM Topical Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 65197 - Wellspring Pharmaceutical Corporation
- 65197-401 - Ad Prevent Original
- 65197-401-99 - 567 g in 1 CARTON
- 65197-401 - Ad Prevent Original
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (65197-401). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65197-401-99 identifies a specific commercial package of 567 g in 1 carton of Ad Prevent Original, a human over the counter drug labeled by Wellspring Pharmaceutical Corporation. This ointment is formulated for topical use and contains lanolin; petrolatum as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Wellspring Pharmaceutical Corporation on October 02, 2023. The current certification is valid through December 31, 2026.
How is this Wellspring Pharmaceutical Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65197040199. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.